Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.62p
   
  • Change Today:
      0.098p
  • 52 Week High: 5.90p
  • 52 Week Low: 1.09p
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 1,604,307
  • Market Cap: £8.08m
  • RiskGrade: 328
  • Beta: 0.08

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £24,076
Lisa Baderoon 583,963 £9,446
Tim Franklin 525,000 £8,492

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £1,050,277
Luca & Associates AG 22,000,000 £355,850
Invesco Ltd 17,872,341 £289,085
Aviva Investors Global 11,285,180 £182,538
Alora Pharmaceuticals LLC 10,909,091 £176,454
M&G Investments 7,600,000 £122,930
Prudential plc 7,600,000 £122,930
Capital Income Builder 4,870,367 £78,778
Dr R Zimmer 4,551,553 £73,621
Odey Asset Management 3,433,319 £55,534
Rhone Trustees (Switzerland) SA 3,386,000 £54,769
Pictet Overseas Trust Corporation Limited 3,287,500 £53,175

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.62p
Change Today 0.098p
% Change 6.41 %
52 Week High 5.90p
52 Week Low 1.09p
Volume 1,604,307
Shares Issued 499.72m
Market Cap £8.08m
Beta 0.08
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.15% below the market average29.15% below the market average29.15% below the market average29.15% below the market average29.15% below the market average
25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average25.58% above the sector average
Price Trend
61.84% below the market average61.84% below the market average61.84% below the market average61.84% below the market average61.84% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 15-Aug-2025

Time Volume / Share Price
16:09 23,448 @ 1.60p
16:08 39,757 @ 1.60p
15:10 70,094 @ 1.65p
14:57 60,243 @ 1.60p
13:39 534 @ 1.50p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page